絞り込み

17752

広告

スターを付ける スターを付ける     (11view , 0users)

Full Text Sources

Medical

Variable response to chemotherapy in acute myeloid leukemia (AML) represents a major treatment challenge. Clinical and genetic features incompletely predict outcome. The value of clinical epigenetic assays for risk classification has not been extensively explored. We assess the prognostic implications of a clinical assay for multilocus DNA methylation on adult patients with de novo AML.
PMID: 27446991 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード